Schrödinger Named Bio-IT World Best Practices Grand Prize Winner
Big 5 Pharma Leverages Cycle Computing Software to Win
Bio-IT World’s IT Infrastructure Grand Prize
New York – May 21, 2013 – Schrödinger, Inc., a scientific leader in chemical simulation for pharmaceutical and biotechnology research, was named the IT infrastructure grand prize winner of Bio-IT World’s best practices award for a 50,000-core utility supercomputer orchestrated by Cycle Computing, leader in Utility HPC software. Conducted in the Amazon Web Services (AWS) cloud, the environment was created to accelerate the screening of potential new cancer drugs.
Schrödinger’s researchers used Cycle’s HPC software to orchestrate the cloud computing resources needed to complete more than 4,480 days of work, nearing 12.5 years of computations, in less than three hours. The project cost less than $4,828 per hour at peak and required no upfront capital. Schrödinger had previously been conducting coarser screens due to the constraints of their internal infrastructure. In contrast, access to large scale yet cost effective computing made it possible to conduct much more granular screens on a significantly larger number of compounds. This approach identified many compounds that were good potential drug candidates that would have otherwise not been discovered.
“We’re honored that our project was recognized by the Bio-IT World judges,” said Dr. Alessandro Monge, Schrödinger’s VP of strategic business. “With the level of sophisticated technology that Cycle provided us, we have significantly eliminated false negatives and false positives that delay drug discovery. The same calculation would’ve been cost prohibitive on our own infrastructure.”
“Our work with Schrödinger demonstrates how scientists can take advantage of innovative technology to complete better research faster and for exponentially less cost,” said Jason Stowe, founder and CEO, Cycle Computing. “We’re thrilled to create HPC environments to empower Schrödinger’s drug discovery breakthroughs and are honored by Bio-IT World’s recognition of their efforts.”
“We extend our sincere congratulations to the winners of this year’s Bio-IT World Best Practices Awards competition,” said Kevin Davies, editor of Bio-IT World. “Our select judges enjoyed evaluating the dozens of excellent entries received this year, and believe that the contest has highlighted some truly innovative, game-changing tools and solutions. Our winners should be very proud that they have captured the imagination and respect of such a distinguished jury.”
About Schrödinger
Schrödinger makes significant investments in R&D, which has led to major advances in the field of computational chemistry; it has achieved breakthroughs in quantum chemistry, molecular modeling, force fields, molecular dynamics, protein structure determination, scoring, and virtual screening. The company's full product offerings range from general molecular modeling programs to a comprehensive suite of drug design software. Besides the company’s industry-leading drug discovery solutions, Schrödinger is actively developing state-of-the art simulation tools for materials research as well as enterprise software that can be deployed throughout an entire research organization. Schrödinger's methods development and applications papers have thousands of citations and are often among the most-cited scientific publications. Schrödinger's science is continually validated internally and by its users worldwide. Founded in 1990, Schrödinger has operations in the United States as well as in Europe, India, and Japan.
About Cycle Computing
Cycle Computing is the leader in Utility HPC software. As a self-funded, profitable software company, Cycle makes award-winning products that accelerate breakthroughs at any scale. From 50 to 50,000+ cores against up to 100s of TBs of data, the world’s brightest minds rely on Cycle software to tackle their most challenging computational problems in less time, for less cost than ever before possible. Cycle software provides the single pane of glass from which customers and partners easily orchestrate complex workloads and data across a right-sized set of internal and external HPC resources. Cycle helps clients maximize existing infrastructure and speed computations on servers, VMs, and on-demand in the cloud, like the 10,000-core cluster for Genentech, the 30,000+ core cluster for a Top 5 Pharma, and the 50,000-core cluster for Schrödinger covered in Wired, TheRegister, BusinessWeek, Bio-IT World, and Forbes. Since 2005, starting with three initial Fortune 100 clients, Cycle has grown to deploy proven implementations at Fortune 500s, SMBs and government and academic institutions including JP Morgan Chase, Purdue University, Pfizer and Lockheed Martin.
About Bio-IT World
Part of the Cambridge Healthtech Institute Media Group, Bio-IT World provides outstanding coverage of cutting-edge trends and technologies that impact the management and analysis of life sciences data, including next-generation sequencing, drug discovery, predictive and systems biology, informatics tools, clinical trials, and personalized medicine. Through a variety of sources including, Bio-ITWorld.com, the Weekly Update Newsletter and the Bio-IT World News Bulletins, Bio-IT World is a leading source of news and opinion on technology and strategic innovation in the life sciences, including drug discovery, development.
# # #
Media Contact:
Shaina Mardinly
Articulate Communications Inc.
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
212.255.0080, ext. 15
|
Home
Documentation
Forums
Blog
Twitter
Contact Us
Sign In